Comparison of the signaling mechanisms by which VEGF, H2O 2, and phosphatase inhibitors activate endothelial cell ERK1/2 MAP-kinase

Microvascular Research

Volumn 69, Issue 1-2, 2005, Pages 36-44

  Tao, Qi ^a   Spring, Simone C ^a   Terman, Bruce I ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Cardiology Division   (United States)

Author keywords

Angiogenesis; Endothelial cells; KDR; MAP kinase; Reactive oxygen; SHP 1, ERK1 2; VEGF

Indexed keywords

HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOLIPASE C GAMMA; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; VANADIC ACID; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ARTICLE; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOLECULAR MIMICRY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 15744393966     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mvr.2004.11.003     Document Type: Article

References (29)

1. Y.S. Bae, S.W. Kang, M.S. Seo, I.C. Baines, E. Tekle, P.B. Chock, and S.G. Rhee Epidermal growth factor (EGF)-induced generation of hydrogen peroxide J. Biol. Chem. 272 1997 217 221
2. K.L. Berg, K.A. Siminovitch, and E.R. Stanley SHP-1 regulation of p62(DOK) tyrosine phosphorylation in macrophages J. Biol. Chem. 274 1999 35855 35865
3. J.D. Bjorge, A. Jakymiw, and D.J. Fujita Selected glimpses into the activation and function of Src kinase Oncogene 19 2000 5620 5635
4. R. Colavitti, G. Pani, B. Bedogni, R. Anzevino, S. Borrello, J. Waltenberger, and T. Galeotti Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR J. Biol. Chem. 277 2002 3101 3108
5. C. de Vries, J.A. Escobedo, H. Ueno, K. Houck, N. Ferrara, and L.T. Williams The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor Science 255 1992 989 991
6. H.F. Dvorak Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J. Clin. Oncol. 20 2002 4368 4380
7. N. Ferrara VEGF and the quest for tumour angiogenesis factors Nat. Rev., Cancer 2 2002 795 803
8. D.Q. Guo, L.W. Wu, J.D. Dunbar, O.N. Ozes, L.D. Mayo, K.M. Kessler, J.A. Gustin, M.R. Baerwald, E.A. Jaffe, R.S. Warren, and D.B. Donner Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation J. Biol. Chem. 275 2000 11216 11221
9. H. He, V.J. Venema, X. Gu, R.C. Venema, M.B. Marrero, and R.B. Caldwell Vascular endothelial growth factor signals cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src J. Biol. Chem. 274 1999 25130 25135
10. B. Keyt, H. Nguyen, L. Berleau, C.M. Duarte, J. Park, H. Chen, and N. Ferrara Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis J. Biol. Chem. 271 1996 5638 5646
11. 2-treated cells and its activation by tyrosine kinase in vitro Proc. Natl. Acad. Sci. 98 2001 6587 6592
12. J. Kroll, and J. Waltenberger The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells J. Biol. Chem. 272 1997 32521 32527
13. M.A. Lindsay Peptide-mediated cell delivery: application in protein target validation Curr. Opin. Pharmacol. 5 2002 587 594
14. E.O. Long Regulation of immune responses through inhibitory receptors Annu. Rev. Immunol. 17 1999 875 904
15. 2 and plays an integral role in insulin signal transduction Mol. Cell. Biol. 24 2004 1844 1854
16. T.-C. Meng, T. Fukada, and N.K. Tonks Reversible oxidation and activation of protein tyrosine phosphatases in vivo Mol. Cell 9 2002 387 399
17. H. Nakagami, T.X. Cui, M. Iwai, T. Shiuchi, Y. Takeda-Matsubara, L. Wu, and M. Horiuchi Tumor necrosis factor-alpha inhibits growth factor-mediated cell proliferation through SHP-1 activation in endothelial cells Arterioscler., Thromb., Vasc. Biol. 22 2002 238 242
18. A. Pedram, M. Razandi, and E.R. Levin Deciphering vascular endothelial growth factor/vascular permeability factor signaling to vascular permeability J. Biol. Chem. 277 2002 44385 44398
19. A. Saaristo, T. Karpanen, and K. Alitalo Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis Oncogene 19 2000 6122 6129
20. Y. Suzaki, M. Yoshizumi, S. Kagami, A.H. Koyama, Y. Taketani, H. Houchi, K. Tsuchiya, E. Takeda, and T. Tamaki Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: potential role in cell survival following oxidative insults J. Biol. Chem. 277 2002 9614 9621
21. T. Takahashi, H. Ueno, and M. Shibuya VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells Oncogene 18 1999 2221 2230
22. T. Takahashi, S. Yamaguchi, K. Chida, and M. Shibuya A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells EMBO J. 20 2001 2768 2778
23. Q. Tao, M.V. Backer, J.M. Backer, and B.I. Terman Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signaling J. Biol. Chem. 276 2001 21916 21923
24. B.I. Terman, M. Dougher-Vermazen, M.E. Carrion, D. Dimitrov, D.C. Armellino, D. Gospodarowicz, and P. Bohlen Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor Biochem. Biophys. Res. Commun. 187 1992 1579 1586
25. H.W. Tsui, K.A. Siminovitch, L. de Souza, and F.W. Tsui Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene Nat. Genet. 4 1993 124 129
26. M. Ushio-Fukai, Y. Tang, T. Fukae, S.I. Dikalov, Y. Ma, M. Fujimoto, M.T. Quinn, P.J. Pagano, C. Johnson, and R.W. Alexander Novel role of gp91(phox)-containing NAD(P)H-oxidase in vascular endothelial growth factor-induced signaling and angiogenesis Circ. Res. 91 2002 1160 1167
27. C. Wu, M. Sun, L. Liu, and G.W. Zhou The function of the protein tyrosine phosphatase SHP-1 in cancer Gene 306 2003 1 12
28. C.C. Yu, H.W. Tsui, B.Y. Ngan, M.J. Shulman, G.E. Wu, and F.W. Tsui B and T cells are not required for the viable motheaten phenotype J. Exp. Med. 183 1996 371 380
29. J. Zhang, A.K. Somani, and K.A. Siminovitch Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling Semin. Immunol. 12 2000 361 378